Mipomersen (ISIS-301012)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mipomersen (ISIS-301012), covering 2013-03-21 to 2013-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease [Phase 3]